Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance

Mariko Shirane; Nobuyo Yawata; Daisuke Motooka; Kensuke Shibata; Seik-Soon Khor; Yosuke Omae; Toshikatsu Kaburaki; Ryoji Yanai; Hisashi Mashimo; Satoshi Yamana; Takako Ito; Akira Hayashida; Yasuo Mori; Akihiko Numata; Yusuke Murakami; Kohta Fujiwara; Nobuyuki Ohguro; Mayumi Hosogai; Masato Akiyama; Eiichi Hasegawa; Michael Paley; Atsunobu Takeda; Katsumi Maenaka; Koichi Akashi; Wayne M Yokoyama; Katsushi Tokunaga; Makoto Yawata; Koh-Hei Sonoda

doi:10.3389/fimmu.2022.1124440

Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance

Front Immunol. 2023 Jan 5:13:1124440. doi: 10.3389/fimmu.2022.1124440. eCollection 2022.

Authors

Mariko Shirane¹, Nobuyo Yawata^{2

3

4}, Daisuke Motooka^{5

6}, Kensuke Shibata^{2

7

8}, Seik-Soon Khor⁹, Yosuke Omae⁹, Toshikatsu Kaburaki^{10

11}, Ryoji Yanai¹², Hisashi Mashimo¹³, Satoshi Yamana¹, Takako Ito¹, Akira Hayashida¹, Yasuo Mori¹⁴, Akihiko Numata¹⁴, Yusuke Murakami¹, Kohta Fujiwara¹, Nobuyuki Ohguro¹³, Mayumi Hosogai¹⁵, Masato Akiyama², Eiichi Hasegawa¹, Michael Paley¹⁶, Atsunobu Takeda¹, Katsumi Maenaka^{17

18

19}, Koichi Akashi¹⁴, Wayne M Yokoyama^{16

20}, Katsushi Tokunaga⁹, Makoto Yawata^{21

22

23

24

25

26}, Koh-Hei Sonoda¹

Affiliations

¹ Department of Ophthalmology, Kyushu University, Fukuoka, Japan.
² Department of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan.
³ Ocular inflammation and Immunology, Singapore Eye Research Institute, Singapore, Singapore.
⁴ Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.
⁵ Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
⁶ Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan.
⁷ Department of Microbiology and Immunology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
⁸ Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
⁹ Genome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
¹⁰ Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
¹¹ Department of Ophthalmology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
¹² Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
¹³ Department of Ophthalmology, Japan Community Health Care Organization Hospital, Osaka, Japan.
¹⁴ Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
¹⁵ Department of Ophthalmology, Gunma University Graduate School of Medicine, Gunma, Japan.
¹⁶ Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
¹⁷ Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
¹⁸ Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
¹⁹ Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan.
²⁰ Bursky Center for Human Immunology and Immunotherapy Programs, Washington University, St. Louis, MO, United States.
²¹ Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research, ASTAR, Singapore, Singapore.
²² Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
²³ Department of Pediatrics, National University Health System, Singapore, Singapore.
²⁴ Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
²⁵ National University Singapore Medicine Immunology Translational Research Programme, National University of Singapore, Singapore, Singapore.
²⁶ International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1008220.].

Keywords: CMV retinitis; CMV viremia; HLA class I; HLA-E; NKG2A; UL40; human cytomegalovirus; natural killer cells.

Copyright © 2023 Shirane, Yawata, Motooka, Shibata, Khor, Omae, Kaburaki, Yanai, Mashimo, Yamana, Ito, Hayashida, Mori, Numata, Murakami, Fujiwara, Ohguro, Hosogai, Akiyama, Hasegawa, Paley, Takeda, Maenaka, Akashi, Yokoyama, Tokunaga, Yawata and Sonoda.

Publication types

Published Erratum